Chronic Lung Disease of Prematurity Recruiting Phase 2 / 3 Trials for Spironolactone (DB00421)

Also known as: Bronchopulmonary Dysplasia / Dysplasia, Bronchopulmonary / Ventilator lung in newborn / Congenital pulmonary fibrosis

IndicationStatusPhase
DBCOND0044076 (Chronic Lung Disease of Prematurity)Recruiting2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01721655Determining the Effect of Spironolactone on Electrolyte Supplementation in Preterm Infants With Chronic Lung DiseaseTreatment